ABSTRACT Background: Vancomycin-induced nephrotoxicity is characterized by acute tubular necrosis (ATN) or interstitial damage (ATIN). Vancomycin-resistance among Enterococci has been escalating in recent years in many countries. Linezolid (LNZ), an oxazolidinone is one of the novel drugs that promised effective therapy of infections caused by vancomycin-resistant Enterococci (VRE). Objectives: The present work aimed to experimentally compare the nephrotoxicity induced by linezolid and vancomycin (VCM) on adult albino rat both biochemically and histopathologically. Methodology: Thirty rats were randomly divided into three groups (10 rats each) Group (I) Control group, Group (II) LNZ group and Group (III) VCM group. To study the toxic effect of linezolid on the kidney in comparison with vancomycin. The level of serum creatinine, urea and malondialdehyde (MDA) were measured. Results: It was found in this study that VCM significantly increase serum creatinine, urea and MDA concentrations compared to the control group, and LNZ insignificantly increase serum creatinine, urea and MDA compared to the control group, with no significant difference between the effects of two drugs. Histopathological study of VCM-treated rat kidney showed marked interstitial nephritis with tubular necrosis and desquamation of tubular epithelial cells. Conclusion and Recommendations: Nephrotoxicity in linezolid-treated rats was less than vancomycin-treated rats. Further studies are needed about effect of linezolid on kidney.
I. INTRODUCTION
he rapid progression and high mortality associated with methicillin-resistant staphylococcal aureus (MRSA) infections and enterococci is a real clinical problem and compels physicians to find a bactericidal solution. Among options, vancomycin and linezolid seem to offer this solution (Barceló-Vidal et al, 2018) . Vancomycin is a timedependent antibiotic with bactericidal activity useful for treating patients with infections caused by Gram-positive microorganisms, including methicillin-resistant Staphylococcus aureus (Barceló-Vidal et al, 2018) .Regarding the nephrotoxicity of vancomycin have accumulated in the literature in the last few decades (Filippone et al, 2017) . These toxicities are related to long periods of treatment, concomitant nephrotoxic agents, high dosages, and high vancomycin plasma trough levels (Rybak et al, 2009 ). Vancomycin-induced nephrotoxicity is characterized by acute tubular necrosis (ATN) or interstitial damage (ATIN), yet the majority of biopsy reports have described (ATIN) rather than ATN (Barceló-Vidal et al, 2018). Vancomycin-resistance among Enterococci has been escalating in recent years in many countries. Linezolid, an oxazolidinone is one of the novel drugs that promised effective therapy of infections caused by vancomycin-resistant Enterococci (VRE) (Hussain et al., 2018 (Schemer, 1967) . Serum was prepared by immediate centrifugation then separated to assay the level of serum creatinine, serum urea and oxidative stress indices: level of serum malondialdehyde (MDA).
II.4.3. Histopathological examination:
After collecting the blood specimens the rats were sacrificed by diethyl ether, the abdomen was opened, and the kidney was cut. The kidney was cleaned from surrounding tissues and fat then fixed in 10 % phosphate buffered formalin. Fixed specimens were prepared for paraffin sections and staining with hematoxylin & eosin according to (Dury and Wallington, 1967) .
II.4.4. Statistical Analysis
Software (SPSS, Version 20.0 for Windows, SPSS Inc, Chicago, IL) was used for analyses of the data. Mean and standard error of the mean (M SE) were used to summarize data. Analysis of variance (ANOVA) (F test) was used for multiple comparisons of quantitative variables after establishing their normal distribution. Post hoc test (LSD) was used for multiple comparisons of quantitative variables. Differences were considered significant at P≤0 .05 and non-significant at P ˃0.05.
III. RESULTS

III.1. Biochemical study:
In the present work negative control, and positive control (solvent) groups, showed a non-significant difference (p>0.05) as regard biochemical parameters (serum urea, creatinine and MAD). So, the mean of all control groups was chosen as a representative group for the two control groups to be compared with the results of the treated groups. 2013) found that LNZ was better than VCM for the treatment of MRSA nosocomial pneumonia when a prospective randomized study was made comparing a fixed linezolid dose to dose-optimized vancomycin for the treatment of MRSA nosocomial pneumonia. Linezolid is a mostly safe antibiotic, when taken for short periods (Marino and Sutin, 2007) . Usage of linezolid for long duration has been associated with bone marrow suppression (Falagas et al, 2008) ,lactic acidosis (Barnhill et al, 2012) and it may be the cause of nerve damage, including may be irreversible optic nerve damage (Saijo et al, 2005) . There are also postmarketing reports of seizures, Bell's palsy and kidney toxicity (Metaxas and Falagas 2009) . In this study we compare between nephrotoxic effect of linezolid and vancomycin in adult albino rats. In the present study, repeated i.p. administration of 200 mg/ kg VCM, for 7 consecutive days to rats, induced a considerable raise in serum creatinine and urea concentrations compared to the control group, suggesting an acute renal failure. These findings are in agreement with the results of other experimentally studies about the nephrotoxicity of VCM (Basarslan et al, 2012; Elyasi et al, 2013 and Konishi et al, 2013) . In the present study, repeated i.p. administration of 50 mg/ kg LNZ, for 7 consecutive days to rats, induced a considerable insignificant raise in serum creatinine and urea concentrations compared to the control group. Esposito et al (2007) reported the first case of linezolidrelated acute renal failure in a patient with kidney transplantation. There was increase in serum creatinine 136-221 micromole/l, with mild hypereosinophilia, anemia and thrombocytopenia, 8 days after starting linezolid therapy. A case of an old female who was treated for prosthetic joint infection and (MRSA) bacteremia with vancomycin followed by linezolid intake. On the seven day of linezolid therapy, the patient had severe pruritus, macular rash, facial edema, eosinophilia, high increase in serum creatinine level, and mild hepatitis (Sébastien et al, 2009 ). Sébastien et al (2009) also found rapid improvement of renal function was due to discontinuation of linezolid and a short term treatment of prednisone. The present study found that VCM significantly increases serum MDA compared to the control group while LNZ increases serum MDA insignificantly, with no significant difference between the effect of two drugs. Although the mechanism of renal toxicity from vancomycin is not fully known, experimental studies maintained proinflammatory oxidation, mitochondrial dysfunction and cellular apoptosis as the principal causes of injury (Oluwatoyin, 2016). Oxidative phosphorylation caused by vancomycin induces free oxygen radicals and so reduces the activity of defensive antioxidative enzymes such as superoxide dismutase and catalases (Oktem et al, 2005) . Ocak et al (2007) found that antioxidative biological agents that successfully used in animal studies as vitamin E, vitamin C, Nacetylcysteine, caffeic acid and phenethyl ester had a protection against vancomycin induced renal damage. Rajitha et al (2011) reported that lipid peroxidation products as MDA was markedly increased by vancomycin. Ahmida (2012) (Wu et al, 2007) . Rajitha et al (2011) found that renal histopathology of vancomycin treated rats showed marked glomerular and tubular damages; which is attenuated by treatment with atorvastatin. Histopathological study of LNZ -treated rat kidney showed cloudy swelling of tubular epithelium with mild interstitial nephritis. Esposito et al (2007) reported that the transplant kidney biopsy, performed 15 days from the start of linezolid therapy, in a case of linezolid-related acute renal failure in a kidneytransplant patient, showed interstitial nephritis and focal tubular atrophy. A case of an old diabetic man with alcoholic cirrhosis admitted in ICU. On the third day of linezolid treatment, there were severe pruritus, macular rash, eosinophilia, and renal dysfunction. Renal biopsy showed acute tubulointerstitial nephritis (Nayak et al, 2012) . Hector et al (2007) reported that seven days after beginning linezolid therapy in a 30-year-old healthy man with tibial osteomyelitis. There were development of a diffuse maculopapular rash and acute renal failure. Acute interstitial nephritis is diagnosed by renal biopsy.
V. Conclusion and Recommendations:
Renal toxicity is one of the most important side effects of VCM; therefore their clinical uses are limited. In our study, we found that nephrotoxicity in linezolid-treated rats less than in vancomycin-treated rats. 
